相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
Federica Ruffini et al.
Journal of Translational Medicine (2015)
Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
Andrea Ladanyi
PIGMENT CELL & MELANOMA RESEARCH (2015)
A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma
Wenbing Dai et al.
DRUG DELIVERY (2015)
Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases
Belal Chaudhary et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin
Federica Ruffini et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1
Yi-Ying Wu et al.
ANGIOGENESIS (2014)
A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway
Fanwei Zeng et al.
ANTI-CANCER DRUGS (2014)
Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening
Anna Starzec et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
Amita Patnaik et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation
Sina Koch et al.
DEVELOPMENTAL CELL (2014)
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
Colin D. Weekes et al.
INVESTIGATIONAL NEW DRUGS (2014)
VEGF-A promotes IL-17A-producing γδ T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells
Takahiro Suzuki et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells
Claudio Raimondi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Immunohistological Insight into the Correlation between Neuropilin-1 and Epithelial-Mesenchymal Transition Markers in Epithelial Ovarian Cancer
Sirin A. I. Adham et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration
Dipak Panigrahy et al.
PATHOLOGY (2014)
Neuropilin-1 Promotes Epithelial-to-Mesenchymal Transition by Stimulating Nuclear Factor-Kappa B and Is Associated with Poor Prognosis in Human Oral Squamous Cell Carcinoma
Weiming Chu et al.
PLOS ONE (2014)
Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
Matija Snuderl et al.
CELL (2013)
Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms
Federica Ruffini et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Markers of Response for the Antiangiogenic Agent Bevacizumab
Diether Lambrechts et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
Greg M. Delgoffe et al.
NATURE (2013)
Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness
Federica Ruffini et al.
ONCOLOGY REPORTS (2013)
Challenging resistance mechanisms to therapies for metastatic melanoma
Lucio Tentori et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Tumor Cell Vasculogenic Mimicry From Controversy to Therapeutic Promise
Richard E. B. Seftor et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Anil Kumar et al.
BIOMATERIALS (2012)
Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in mice
Daniela Bumbaca et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Neuropilin-1 Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
Usman Yaqoob et al.
CANCER RESEARCH (2012)
Pharmacokinetic and Pharmacodynamic Analysis of Circulating Biomarkers of Anti-NRP1, a Novel Antiangiogenesis Agent, in Two Phase I Trials in Patients with Advanced Solid Tumors
Yan Xin et al.
CLINICAL CANCER RESEARCH (2012)
Neuropilins: expression and roles in the epithelium
Jonathan R. L. Wild et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2012)
MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1
Yi Cui et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
Wiebke Hansen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Neuropilin-1 expression in cancer and development
Adrian M. Jubb et al.
JOURNAL OF PATHOLOGY (2012)
Transtumoral targeting enabled by a novel neuropilin-binding peptide
L. Roth et al.
ONCOGENE (2012)
microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer
Yujun Zhang et al.
ONCOLOGY REPORTS (2012)
Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity
Gerald J. Prud'homme et al.
ONCOTARGET (2012)
Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas
Caroline Pellet-Many et al.
BIOCHEMICAL JOURNAL (2011)
Targeting neuropilin-1 in human leukemia and lymphoma
Katja Karjalainen et al.
BLOOD (2011)
Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
Kurt Ballmer-Hofer et al.
BLOOD (2011)
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-kappa B
Lauretta Levati et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Neuropilin-1 Signaling through p130Cas Tyrosine Phosphorylation Is Essential for Growth Factor-Dependent Migration of Glioma and Endothelial Cells
Ian M. Evans et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
VEGF Signaling through Neuropilin 1 Guides Commissural Axon Crossing at the Optic Chiasm
Lynda Erskine et al.
NEURON (2011)
Neuropilins: A New Target for Cancer Therapy
Camille Grandclement et al.
Cancers (2011)
Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner
Tzvetanka Bondeva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular Carcinoma
Mathieu Berge et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo
Monika Edelbauer et al.
BLOOD (2010)
Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity
H. Jia et al.
BRITISH JOURNAL OF CANCER (2010)
Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction
Ashley Jarvis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1
Kakali Dhar et al.
MOLECULAR CANCER (2010)
Hormonal Regulation and Distinct Functions of Semaphorin-3B and Semaphorin-3F in Ovarian Cancer
Doina Joseph et al.
MOLECULAR CANCER THERAPEUTICS (2010)
From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway
Ricardo J. Giordano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Kazuki N. Sugahara et al.
SCIENCE (2010)
Inhibition of Neuropilin-1 by RNA-Interference and its Angiostatic Potential in the Treatment of Hepatocellular Carcinoma
E. Raskopf et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2010)
Anti-angiogenesis therapies: their potential in cancer management
Andrew Gaya et al.
OncoTargets and Therapy (2010)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis
Puja Gaur et al.
CLINICAL CANCER RESEARCH (2009)
αvβ3 Integrin Limits the Contribution of Neuropilin-1 to Vascular Endothelial Growth Factor-induced Angiogenesis
Stephen D. Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin
Lorena Capparuccia et al.
JOURNAL OF CELL SCIENCE (2009)
Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration
Yanmei Lu et al.
MABS (2009)
Spontaneous regression of metastases from melanoma: review of the literature
Louise Vennegaard Kalialis et al.
MELANOMA RESEARCH (2009)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Tambet Teesalu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neuropilin-1/GIPC1 Signaling Regulates alpha 5 beta 1 Integrin Traffic and Function in Endothelial Cells
Donatella Valdembri et al.
PLOS BIOLOGY (2009)
Neuropilins: structure, function and role in disease
Caroline Pellet-Many et al.
BIOCHEMICAL JOURNAL (2008)
Neuropilin-1 Upholds Dedifferentiation and Propagation Phenotypes of Renal Cell Carcinoma Cells by Activating Akt and Sonic Hedgehog Axes
Ying Cao et al.
CANCER RESEARCH (2008)
Semaphorin3a disrupts podocyte foot processes causing acute proteinuria
R. Tapia et al.
KIDNEY INTERNATIONAL (2008)
Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells
Lin Lu et al.
LEUKEMIA & LYMPHOMA (2008)
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
Gera Neufeld et al.
NATURE REVIEWS CANCER (2008)
Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1
Arikira Matsushita et al.
CANCER RESEARCH (2007)
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding
Brent A. Appleton et al.
EMBO JOURNAL (2007)
Targeting neuropilin 1 as an antitumor strategy in lung cancer
Tse-Ming Hong et al.
CLINICAL CANCER RESEARCH (2007)
Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library
We-Ching Liang et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Neuropilins Novel Targets for Anti-Angiogenesis Therapies
Elena Geretti et al.
CELL ADHESION & MIGRATION (2007)
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth
Qi Pan et al.
CANCER CELL (2007)
Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1
Anna Starzec et al.
LIFE SCIENCES (2006)
Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1
Snigdha Banerjee et al.
MOLECULAR CARCINOGENESIS (2006)
Antiproliferative effect of semaphorin 3F on human melanoma cell lines
Isabelle Chabbert-de Ponnat et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor
Marcella Marcellini et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Functional interaction of VEGF-C and VEGF-D with neuropilin receptors
Terhi Karpanen et al.
FASEB JOURNAL (2006)
Selective regulation of arterial branching morphogenesis by synectin
Thomas W. Chittenden et al.
DEVELOPMENTAL CELL (2006)
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor Exon 8 for NP-1 binding and role of NP-1 in KDR signaling
HY Jia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2
DC West et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract
DE Hansel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Identification of two novel altematively spliced Neuropilin-1 isoforms
FC Cackowski et al.
GENOMICS (2004)
Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration
L Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo
G Schuch et al.
BLOOD (2002)
Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2
A Kumanogoh et al.
NATURE (2002)
Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain
R Mamluk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression
HQ Miao et al.
FASEB JOURNAL (2000)
Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor
PM Lacal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF
Z Gluzman-Poltorak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:: In vivo expression and antitumor activity
ML Gagnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
